San Francisco biotech Osanni Bio, looking to build out a suite of ophthalmology- and cardiology-focused
June 23, 2026 02:47 PM EDT
FinancingStartups
Osanni Bio gets $190M to build ophthalmology and cardiology pipeline
Kyle LaHucik
Biotech Correspondent
The trend continues in which big-name venture investors band together to back new companies with an experimental medicine…
Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.
San Diego's cAMPfield Therapeutics raises $180M Series A backed by Novo Holdings, RA Capital and seven other top-tier life…
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a
OliX Pharmaceuticals Secures KRW 110 Billion Investment from BOLD, L’Oréal Corporate Venture Capital Fund, and Weiss, U.S. Hedge…
Contraline closes $92.5M Series B to fund male contraception; Novartis begins Phase 3 actinium therapies; Tavo gets $17M Series A.
